FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281953808> ?p ?o ?g. }

• W4281953808 endingPage "93" @default.
• W4281953808 startingPage "86" @default.
• W4281953808 abstract "Abstract Aim To compare the risks of adverse events 3 months after Onabotulinumtoxin‐A and Lanbotulinumtoxin‐A injections in children with cerebral palsy (CP) and to identify risk factors and associations. Method A total of 1037 children (682 males, 355 females; mean age 5 years 2 months [SD 3 years]; age range 2 years–17 years 10 months) with CP underwent 1013 Onabotulinumtoxin‐A injections and 418 Lanbotulinumtoxin‐A injections from 2012 to 2021. Information was recorded in a purpose‐built database. Results The adverse event rates of Onabotulinumtoxin‐A and Lanbotulinumtoxin‐A were reported as 13.92% and 11.96% respectively. Most adverse events were mild and self‐limiting. Children in Gross Motor Function Classification System (GMFCS) levels IV to V had a higher risk of adverse events than those in GMFCS levels I to III (odds ratio [OR] [95% confidence interval {CI}] = 3.65 [1.56, 5.40], p < 0.01). The history of recent illness and higher dose increased the likelihood of adverse events (OR [95% CI] = 2.00 [1.55, 3.00] and 2.20 [1.53, 3.07] respectively, p < 0.01). Sex, age, and the number of injections had no significant effect on adverse event rates ( p > 0.05). The incidence of upper respiratory tract infection and lower respiratory tract infection after injections was weakly correlated with the incidence before injections (r = 0.36 and r = 0.27 respectively, p < 0.01). Interpretation Occurrence of adverse events was similar between Onabotulinumtoxin‐A and Lanbotulinumtoxin‐A in children with CP. Dose, GMFCS level, and health background were risk factors. What this paper adds The prevalence of adverse events was similar between Onabotulinumtoxin‐A and Lanbotulinumtoxin‐A in children with cerebral palsy (CP). The prevalence of adverse events increased with the severity of CP and the injected dose. Sex, age, and number of injections had no significant effect on the prevalence of adverse events." @default.
• W4281953808 created "2022-06-13" @default.
• W4281953808 creator A5000490843 @default.
• W4281953808 creator A5008608315 @default.
• W4281953808 creator A5012957163 @default.
• W4281953808 creator A5017713277 @default.
• W4281953808 creator A5044105188 @default.
• W4281953808 creator A5044991862 @default.
• W4281953808 creator A5046292715 @default.
• W4281953808 creator A5048918491 @default.
• W4281953808 creator A5062912645 @default.
• W4281953808 creator A5080387455 @default.
• W4281953808 date "2022-06-08" @default.
• W4281953808 modified "2023-10-06" @default.
• W4281953808 title "Adverse events after different forms of botulinum neurotoxin A injections in children with cerebral palsy: An 8‐year retrospective study" @default.
• W4281953808 cites W1542422384 @default.
• W4281953808 cites W188697491 @default.
• W4281953808 cites W1973096456 @default.
• W4281953808 cites W2015719646 @default.
• W4281953808 cites W2055205566 @default.
• W4281953808 cites W2077298856 @default.
• W4281953808 cites W2098776203 @default.
• W4281953808 cites W2102894708 @default.
• W4281953808 cites W2105955941 @default.
• W4281953808 cites W2120537253 @default.
• W4281953808 cites W2176370995 @default.
• W4281953808 cites W2337108558 @default.
• W4281953808 cites W2525717392 @default.
• W4281953808 cites W2732623298 @default.
• W4281953808 cites W2738773321 @default.
• W4281953808 cites W2756131896 @default.
• W4281953808 cites W2790353762 @default.
• W4281953808 cites W2889405860 @default.
• W4281953808 cites W2897830585 @default.
• W4281953808 cites W2944259905 @default.
• W4281953808 cites W2954377047 @default.
• W4281953808 cites W2955907617 @default.
• W4281953808 cites W2985340819 @default.
• W4281953808 cites W3008116559 @default.
• W4281953808 cites W3027485054 @default.
• W4281953808 cites W3034501364 @default.
• W4281953808 cites W3165224300 @default.
• W4281953808 cites W3165485314 @default.
• W4281953808 cites W4211074903 @default.
• W4281953808 doi "https://doi.org/10.1111/dmcn.15305" @default.
• W4281953808 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35674175" @default.
• W4281953808 hasPublicationYear "2022" @default.
• W4281953808 type Work @default.
• W4281953808 citedByCount "1" @default.
• W4281953808 countsByYear W42819538082022 @default.
• W4281953808 crossrefType "journal-article" @default.
• W4281953808 hasAuthorship W4281953808A5000490843 @default.
• W4281953808 hasAuthorship W4281953808A5008608315 @default.
• W4281953808 hasAuthorship W4281953808A5012957163 @default.
• W4281953808 hasAuthorship W4281953808A5017713277 @default.
• W4281953808 hasAuthorship W4281953808A5044105188 @default.
• W4281953808 hasAuthorship W4281953808A5044991862 @default.
• W4281953808 hasAuthorship W4281953808A5046292715 @default.
• W4281953808 hasAuthorship W4281953808A5048918491 @default.
• W4281953808 hasAuthorship W4281953808A5062912645 @default.
• W4281953808 hasAuthorship W4281953808A5080387455 @default.
• W4281953808 hasConcept C120665830 @default.
• W4281953808 hasConcept C121332964 @default.
• W4281953808 hasConcept C126322002 @default.
• W4281953808 hasConcept C156957248 @default.
• W4281953808 hasConcept C167135981 @default.
• W4281953808 hasConcept C1862650 @default.
• W4281953808 hasConcept C187212893 @default.
• W4281953808 hasConcept C197934379 @default.
• W4281953808 hasConcept C2776012195 @default.
• W4281953808 hasConcept C2776659555 @default.
• W4281953808 hasConcept C2779421357 @default.
• W4281953808 hasConcept C42219234 @default.
• W4281953808 hasConcept C44249647 @default.
• W4281953808 hasConcept C534529494 @default.
• W4281953808 hasConcept C61511704 @default.
• W4281953808 hasConcept C71924100 @default.
• W4281953808 hasConceptScore W4281953808C120665830 @default.
• W4281953808 hasConceptScore W4281953808C121332964 @default.
• W4281953808 hasConceptScore W4281953808C126322002 @default.
• W4281953808 hasConceptScore W4281953808C156957248 @default.
• W4281953808 hasConceptScore W4281953808C167135981 @default.
• W4281953808 hasConceptScore W4281953808C1862650 @default.
• W4281953808 hasConceptScore W4281953808C187212893 @default.
• W4281953808 hasConceptScore W4281953808C197934379 @default.
• W4281953808 hasConceptScore W4281953808C2776012195 @default.
• W4281953808 hasConceptScore W4281953808C2776659555 @default.
• W4281953808 hasConceptScore W4281953808C2779421357 @default.
• W4281953808 hasConceptScore W4281953808C42219234 @default.
• W4281953808 hasConceptScore W4281953808C44249647 @default.
• W4281953808 hasConceptScore W4281953808C534529494 @default.
• W4281953808 hasConceptScore W4281953808C61511704 @default.
• W4281953808 hasConceptScore W4281953808C71924100 @default.
• W4281953808 hasFunder F4320321001 @default.
• W4281953808 hasFunder F4320321921 @default.
• W4281953808 hasIssue "1" @default.
• W4281953808 hasLocation W42819538081 @default.
• W4281953808 hasLocation W42819538082 @default.

• next